Introduction
A polymorphism of the CETP gene (CETP/TaqIB) with two alleles B1 (60%) and B2 (40%) has been investigated in relation to lipid variables and the risk of myocardial infarction in a large case-control study (ECTIM) of men aged . No association was observed between the polymorphism and LDL or VLDL related lipid variables. Conversely, B2 carriers had reduced levels of plasma CETP (P < 0.0001) and increased levels of HDL cholesterol (P < 0.0001) and of other HDL related lipid variables. The effects of the polymorphism on plasma CETP and HDL cholesterol were independent, suggesting the presence of at least two functional variants linked to B2. A search for these variants on the coding sequence of the CETP gene failed to identify them. The effect of B2 on plasma HDL cholesterol was absent in subjects drinking < 25 grams/d of alcohol but increased commensurably, with higher values of alcohol consumption (interaction: P < 0.0001). A similar interaction was not observed for plasma CETP. The odds-ratio for myocardial infarction of B2 homozygotes decreased from 1.0 in nondrinkers to 0.34 in those drinking 75 grams/d or more. These results provide the first demonstration of a geneenvironment interaction affecting HDL cholesterol levels and coronary heart disease risk. (J. Clin. Invest. 1995. 96:1664-1671.) Key words: alcohol drinking * carrier proteins * high density lipoprotein cholesterol * myocardial infarction * restriction fragment length polymorphisms Plasma high density lipoprotein (HDL) cholesterol is negatively related to the risk of coronary heart disease (CHD) l ( 1, 2) and alcohol consumption is associated with a decreased incidence of CHD, apparently through an increase in plasma HDL cholesterol (3) . Part of the relation between alcohol consumption and HDL cholesterol is mediated by the effect of alcohol on cholesteryl ester transfer protein (CETP) activity (4, 5) . In alcoholics, CETP activity is low and increases after ethanol withdrawal (6) (7) (8) ; moreover, moderate alcohol intake induces a decrease of CETP activity (9) . The role of CETP is to promote transfer of cholesteryl ester from the core of HDL particles to triglyceride-rich lipoproteins, in exchange for triglycerides (4, 5) . Recent data show that an increased transfer of cholesteryl esters from HDL to very low density lipoproteins (VLDL) and low density lipoproteins (LDL) may characterize patients with established coronary artery disease (10) . An increased CETP activity by reducing the cholesterol content of HDL relative to LDL and VLDL could thus contribute to an increased risk of CHD. Furthermore, major deficiencies of the CETP gene are associated with high levels of HDL cholesterol (11) (12) (13) and possibly increased life span (12) . A frequent TaqI polymorphism (CETP/TaqIB) of the CETP gene is associated with plasma HDL cholesterol, individuals carrying the B2 allele (absence of cutting site) having the highest levels of HDL cholesterol (14) (15) (16) (17) (18) .
Since plasma HDL cholesterol and other related parameters, including apolipoprotein (apo) Al and lipoprotein particle (Lp) Al, as well as alcohol consumption are important discriminant factors between cases with myocardial infarction (MI) and controls in the ECTIM study (19) , the CETP gene was considered as a possible candidate for MI and its polymorphism was investigated. Possible associations between CETP/TaqIB and different plasma lipid parameters (including CETP mass) were investigated in control subjects and the distribution of CETP genotypes was compared between cases and controls. Each analysis was also performed according to alcohol consumption. Finally, the CETP gene was screened for variants linked to the CETP/ TaqIB polymorphism.
Methods
Study populations and sampling of cases and controls. Study populations and sampling of cases and controls have been described elsewhere (24) . Among the 10 individuals selected for this analysis, 7 had high plasma HDL cholesterol levels and were homozygous for the less frequent CETP/TaqIB allele (B2) and 3 had low plasma HDL cholesterol levels and were homozygotes for the more frequent allele (B1). Three intronic variants were identified by singlestrand conformation polymorphism and sequencing (25) All polymorphisms, except CETP/TaqIB, were analyzed in the EC-TIM study by allele-specific oligonucleotide hybridization (24, 27) , the probes used and assay conditions are provided in Table I the dependent variable was HDL cholesterol or CETP and the independent variables were the genotypes and alcohol consumption. The interaction term involving both independent variables was also tested. Genotype frequencies were compared between cases and controls by logistic regression analysis, the independent variables were the genotypes and alcohol consumption. Here again the interaction between the two independent variables was tested. Odds-ratios and their 95% confidence intervals were computed from the logistic regression coefficients and their standard errors.
Since the ECTIM study consists of independent studies in four populations, homogeneity of the results in the different populations was tested and the statistical tests were adjusted on population. Homogeneity across population was checked by adding an independent term for population in the regression models and testing the interaction term involving population and genotypes and alcohol consumption. Most tables report results adjusted on population.
In the control groups, the genotype frequencies of the different polymorphisms were not significantly different from Hardy-Weinberg expectation.
Results
Lipid-related variables were first analyzed in the control group to avoid a potential bias resulting from post-MI changes. The frequency of the CETP/TaqIB 2 (B2) allele was similar in the four populations (40%) and did not differ according to alcohol consumption. As shown in Table II , HDL related variables (HDL cholesterol, apolipoproteins Al and All, LpAI and LpAI:AII) were associated with the CETP/TaqLB polymorphism (P < 0.001, except for LpAI:AII, P < 0.05). The B2 allele was associated with an increased plasma concentration of these variables, especially in homozygotes. Lower plasma concentrations of CETP were observed in subjects carrying the B2 allele, with a dose effect (P < 0.0001). Conversely, no association was observed for the other lipid variables: LDL cholesterol and triglycerides (Table II) , total and VLDL cholesterol, apoB, apoCIII, apoE, LpE:B, and LpCIII:B (not shown). Plasma HDL cholesterol and CETP were uncorrelated (r =-0.04, NS), this was true in individuals with genotypes BIBi (r = 0.00, NS), and B2B2 (r = -.02) and the association between B2 and HDL related variables remained highly significant after adjustment on plasma CETP (Table II) . The differences between genotypes were homogeneous across the four population samples included in the ECTIM study for all lipid variables except plasma CETP. As shown in Table III , the lack of homogeneity across populations for plasma CETP was principally due to a reduced genotypic effect in Strasbourg. Although a similar trend existed for HDL cholesterol, there was no significant lack of homogeneity of genotypic effect across populations for this variable.
The effect of B2 on HDL cholesterol was absent in nonalcohol drinkers but increased with alcohol consumption (Table  IV) , this heterogeneity of effect is reflected by the highly significant interaction (P < 0.0001). Among those individuals consuming 75 grams/d of alcohol or more, B1B2 heterozygotes and B2B2 homozygotes had, respectively, a 13 and 30% higher mean plasma HDL cholesterol level than BlB1 homozygotes. For the other HDL related variables, similar interactions between the B2 allele and alcohol consumption were observed (data not shown). Conversely, alcohol consumption had no effect on plasma CETP concentration whatever the genotype of CETP and the genetic effect on CETP concentration was not influenced by alcohol consumption (Table IV) ANOVA of HDL cholesterol: population (NS), CETP/TaqIB (P < 0.0001), interaction (NS). ANOVA of CETP: population (P < 0.0001), CETP/ TaqIB (P < 0.0001), interaction (P < 0.025).
B2 allele in the four populations; however, a significant interactrols), the results were similar to those reported for the whole tion (P < 0.05) between genotypes and population was obstudy group. served which reflected a weaker association in Strasbourg.
Comparisons of relevant characteristics in patients with MI All of these analyses were also performed after exclusion and controls are provided in Table VI . Patients were 1 yr older of subjects treated with lipid-lowering drugs (6% among con-(P < 0.05) and had a 16.5% lower plasma HDL cholesterol Table IV ) and are adjusted on population. In the logistic regression analysis, the interaction term involving presence of genotype 22 and alcohol consumption was statistically significant: P = 0.034. 1 P < 0.02, no significant heterogeneity across center, the corresponding odds-ratios in Belfast and France were 0.28 (0.07-1.1) and 0.44 (0.14-1.39), respectively.
Discussion
This study of large representative samples confirms the already known relationship between the CETP/TaqIB polymorphism and plasma HDL cholesterol (14) (15) (16) (17) (18) (15, 18 ) the CETP/TaqIB polymorphism was associated with CETP activity, whereas it was not in another study (17) . Freeman et al. (17) postulated that differences in activity could be seen only in extreme situations (i.e., hyperalphalipoproteinemia) and that in the general population changes in activity were not responsible for the relation between the CETP gene polymorphism and HDL levels. These results suggested that mutations of the CETP protein might influence its substrate specificity. The measurement of CETP mass (21 ) in the ECTIM study would probably not be influenced by differences in substrate specificity resulting from a sequence polymorphism of the CETP protein. However, the likelihood of frequent sequence changes in the protein is small given the absence of any variation in the coding sequence of 14 B2 alleles. Although the implication of a gene located in the vicinity of the CETP gene cannot be excluded, it is more probable that the functional variant(s) responsible for the effects observed on plasma HDL cholesterol is located in a region involved in the expression of the gene or the processing of its product.
The important role played by environmental factors in the modulation of the expression of the CETP gene is supported by experiments in which the human gene and its flanking regulatory sequences were transfected in mice (28) . In these studies, hepatic CETP mRNA was markedly induced and plasma CETP mass and activity increased in response to a high cholesterol diet. In contrast, such modifications were not observed in mice in which the expression of the CETP gene was controlled by a nonspecific promoter. These results show that the natural flanking regions of the CETP gene contain elements that mediate the increased transcription of the gene in response to dietary cholesterol.
Given the strong effect of alcohol consumption on HDL cholesterol in B2B2 homozygotes, a commensurate inverse effect on plasma CETP concentration would have been expected. The fact that this was not observed could be due to a reduced catabolism of apoAl-containing lipoproteins, the main carriers of CETP, induced by alcohol consumption (29) . It is known that lipolysis of VLDL by lipoprotein lipase stimulates the transfer of esterified cholesterol from HDL to VLDL (4) and that alcohol intake stimulates lipoprotein lipase (30, 31) . A functional variant linked to the B2 allele, by interfering with the normal transcription of the CETP gene, might impair the increased transfer of cholesteryl esters from HDL to VLDL expected in response to lipolysis. Since plasma HDL cholesterol and CETP are uncorrelated, this phenomenon could take place in the postprandial state and/or locally, in the adipose tissue for example. It may be relevant to note that in an animal model the local adipose tissue CETP mRNA was more strongly related with plasma HDL cholesterol than with plasma CETP concentration (32) , thus suggesting that local transfer activity may contribute to the plasma level of HDL cholesterol. These postulated mechanisms are highly speculative, however, and metabolic studies will be needed to resolve the issue.
In studies in Finland (33) , and Sri Lanka (16), the CETP/ TaqIB polymorphism was not associated (33) or only weakly associated with HDL cholesterol ( 16) and no effect on coronary risk could be demonstrated. This may be due to the small sample size of these studies or to the low alcohol consumption in the populations concerned.
The stronger effect of the CETP polymorphism on LpAI than on LpAI:AII particles is consistent with the fact that CETP is mainly present in LpAI and absent from LpAI:AII (34) . Furthermore, it is known that LpAI increases the efflux of cholesterol from cultured cells in vitro while LpAI:AII does not promote this effect (35) . Thus, it has been proposed that LpAI could constitute the antiatherogenic fraction of HDL (35) . The results of the ECTIM study are compatible with this hypothesis ( 19) and they suggest that CETP may play a role in determining the relative amount of LpAI and LpAI:AII in the plasma.
Recently, Inazu et al. (26) identified three variants of the CETP gene in the Japanese population, a G to A substitution in intron 14 (IN14A), an insertion of a T at position +3 from the exon 14/intron 14 junction (IN14T), and a missense mutation within exon 15 (D442G). The percentage of subjects carrying the IN14A and D442G variants was 6.9 and 1.8%, respectively, whereas IN14T was less frequent. Interestingly, these variants accounted for 10% of the variability of HDL cholesterol in a sample of Japanese subjects unselected for HDL cholesterol level. In the ECTIM study we genotyped 366 individuals for these polymorphisms, only 1 individual was heterozygote for IN14A, no variant could be identified for the other sites. It may be concluded that these variants, which are relatively frequent in the Japanese population, are very rare in Caucasians.
In conclusion, these data demonstrate an interaction between alcohol consumption and a frequent polymorphism of the CETP gene on plasma HDL cholesterol and the risk of MI. This interaction is of similar magnitude in the high risk population of Belfast and in France and apparently does not contribute to the difference in CHD frequency between the two countries. The protective variant linked to the B2 allele was not found on the coding sequence of the gene, so it is possibly located in a region involved in the regulation of the expression of the gene. Therefore, we may surmise that it acts by modifying the interaction of such a region with a trans-acting factor that may be modulated by alcohol consumption.
